| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-15 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-15 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |